What's new in hepatitis delta virus?

Area of Science:

• Hepatology
• Virology
• Infectious Diseases

Background:

• Hepatitis delta virus (HDV) is a unique infectious agent requiring hepatitis B virus (HBV) for its life cycle.
• HDV possesses a small RNA genome, distinct from other RNA viruses and viroids.
• HDV infection can occur concurrently with HBV or as a superinfection in chronic HBV carriers.

Purpose of the Study:

• To summarize current knowledge on HDV, its characteristics, transmission, and epidemiology.
• To highlight the clinical implications of HDV infection, particularly superinfection in chronic HBV carriers.
• To outline ongoing research directions for a deeper understanding of HDV.

Main Methods:

• Review of seven years of clinical and laboratory research.
• Analysis of animal experiments and clinical studies on HDV transmission and outcomes.
• Mention of DNA-RNA hybridization as a sensitive detection method for HDV RNA.

Main Results:

• HDV superinfection in chronic HBV carriers can lead to severe, sometimes fatal, acute hepatitis and chronic liver disease in 30-40% of cases.
• HDV is globally distributed with high endemicity in Italy, Arab countries, and specific risk groups like intravenous drug users and hemophiliacs.
• Suspected high endemicity areas for HDV include parts of Africa.

Conclusions:

• HDV represents a significant etiological agent in liver disease, particularly in conjunction with HBV.
• Further epidemiological studies are needed to identify all endemic regions.
• Continued research, including advanced molecular techniques, is crucial for understanding HDV's role in liver disease and its interaction with HBV.